A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups

Addiction

Volumn 102, Issue SUPPL. 2, 2007, Pages 43-57

  Fernander, Anita F ^b   Shavers, Vickie L ^c   Hammons, George J ^a  

^a PHILANDER SMITH COLLEGE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biopsychosocial; Health disparities; Racially classified social groups; Tobacco

Indexed keywords

BIOLOGICAL FACTOR; CYTOCHROME P450 2A6; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; NICOTINE;

ALCOHOL CONSUMPTION; CARDIOVASCULAR RISK; COMORBIDITY; CONCEPTUAL FRAMEWORK; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ETHNIC GROUP; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIFESTYLE; MENTAL STRESS; OBESITY; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PUBLIC HEALTH PROBLEM; REVIEW; SMOKING HABIT; SOCIAL PSYCHOLOGY; TOBACCO DEPENDENCE;

ETHNIC GROUPS; HEALTH STATUS; HUMANS; SOCIOECONOMIC FACTORS; TOBACCO USE DISORDER;

EID: 34548545324     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01954.x     Document Type: Review

References (212)

1. ALA. Smoking and African American Fact Sheet, June 2006. Available at: http://www.lungwsa.org/site/pp.asp?c=dvLUK9OoE&b=35988 (accessed 17 July 2007).
2. US Department of Health and Human Services. Health Consequences of Tobacco Use Among Four Racial/Ethnic Minority Groups. Atlanta, GA : Centers for Disease Control and Prevention 1998.
3. US Department of Health and Human Services. Tobacco Use Among US Racial/Ethnic Groups - African Americans. American Indian and Alaska Natives. Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General. Atlanta, GA : Centers for Disease Control and Prevention 1998.
4. Peto R., Lopez A. D., Boreham J., Thun M., Heath C. Doll R. Mortality from smoking worldwide. Br Med Bull 1996 52 : 12 21.
5. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost and economic costs - United States, 1995-1999. MMWR 2002 51 : 300 3.
6. American Heart Association Heart facts. All Americans. Dallas, TX : American Heart Association 2002.
7. Centers for Disease Control and Prevention. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity - United States, 1990-1998. MMWR 2002 51 : 49 53.
8. Edwards B. K., Brown M. L., Wingo P. A., Howe H. L., Ward E., Ries L. A. et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005 97 : 1407 27.
9. Renner C. C., Patten C. A., Enoch C., Petraitis J., Offord K. P., Angstman S. et al. Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventions. Prev Med 2004 38 : 421 31.
10. Stellman S. D., Chen Y., Muscat J. E., Djordjevic M. V., Richie J. P., Lazarus P. et al. Lung cancer risk in white and black Americans. Ann Epidemiol 2003 13 : 294 302.
11. US Department of Health and Human Services. Patterns of Tobacco use Among Four Racial/Ethnic Minority Groups. Atlanta, GA : Centers for Disease Control and Prevention 1998.
12. Gust S. W., Pickens R. W., Pechacek T. F. Relation of puff Volume to other topographical measures of smoking. Addict Behav 1983 8 : 115 19.
13. Heishman S. J., Stitzer M. L., Yingling J. E. Effects of tetrahydrocannobinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav 1989 14 : 184 206.
14. Jarvik M. E., Tashkin D. P., Caskey N. H., McCarthy W. J., Rosenblatt M. R. Mentholated cigarettes decreases puff Volume of smoke and increase carbon monoxide absorption. Physiol Behav 1994 56 : 563 70.
15. Bridges R. B., Combs J. G., Humble J. W., Turbek J. A., Rehm S. R., Haley N. J. Puffing topography as a determinant of smoke exposure. Pharmacol Biochem Behav 1990 37 : 29 39.
16. Association of Schools of Public Health. Harvard Researchers Gather More Evidence Implicating Menthol in Health Disparities Between White and Black Smokers, ASPH Friday Letter #1375. AUGUST 26, 2005. Available at: http://www.asph.org/press/fridayletter/article_view.cfm?fl_index= 1375&fle_index=2548 (accessed 27 February 2006).
17. Harris J. E., Thun M. J., Mondul A. M., Calle E. E. Cigarette tar yields in relation to mortality from lung cancer in the Cancer Prevention Study II prospective cohort 1982-8. Br Med J 2004 328 : 72 80.
18. Ahijevych K., Gillespie J. Nicotine dependence and smoking topography among Black and White women. Res Nurs Health 1997 20 : 505 14.
19. Stolerman I. P., Jarvis M. J. The scientific case that nicotine is addictive. Psychopharmacol (Berl) 1995 117 : 2 10.
20. Pidoplichko V. I., DeBiasi M., Williams J. T., Dani J. A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997 390 : 401 4.
21. Pontieri F. E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996 382 : 255 7.
22. Salokangas R. K., Vilkman H., Ilonen T., Taiminen T., Bergman J., Haaparanta M. et al. High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 2000 157 : 632 4.
23. Laviolette S. R., van der Kooy D. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 2003 8 : 50 9.
24. Stein E. A., Pankiewicz J., Harsch H. H., Cho J. K., Fuller S. A., Hoffman R. G. et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 1998 155 : 1009 15.
25. Koob G. F. Neurobiology of addiction: toward the development of new therapies. Ann NY Acad Sci 2000 909 : 170 85.
26. Wommacott S., Sidhpura N., Balfour D. J. K. Nicotine: from molecular mechanisms to behavior. Curr Opin Pharmacol 2005 5 : 53 9.
27. Watkins S. S., Koob G. F., Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2000 2 : 19 37.
28. Rose J. E., Behm F. M., Ramsey C., Ritchie J. C. Jr. Platelet monamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res 2001 3 : 383 90.
29. Holm H., Jarvis M. J., Russell M. A., Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 1992 108 : 507 11.
30. Woody G. E., Cottler L. B., Cacciola J. Severity of dependence: data from the DSM-IV field trials. Addiction 1993 88 : 1573 9.
31. Kandel D. B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res 2000 2 : 263 74.
32. Carabello R., Giovino G., Pechacek T., Mowery P., Richter P., Strauss W. et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: third national health and nutrition examination survey, 1988-1991. J Am Med Assoc 1998 280 : 135 9.
33. Okuyemi K. S., Richter K. P., Ahluwalia J. S., Mosier M. C., Nazir N., Resnicow K. Smoking reduction practices among African American smokers. Nicotine Tob Res 2002 4 (Suppl. 2 S167 73.
34. Andreski P., Breslau N. Smoking and nicotine dependence in young adults: differences between blacks and whites. Drug Alcohol Depend 1993 32 : 119 25.
35. Ahluwalia J. S., Reniscow K., Clark S. Knowledge about smoking, reasons for smoking, and reasons for wishing to quit in inner-city African Americans. Ethn Dis 1998 8 : 385 93.
36. Kandel D., Chen K., Warner L. A., Kessler R. C., Grant B. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend 1997 44 : 11 29.
37. Clemmey P., Brooner R., Chutuape M. A., Kidorf M., Stitzer M. Smoking habits and attitudes in a methodone maintenance treatment population. Drug Alcohol Depend 1997 44 : 123 32.
38. Berlin I., Radzius A., Henningfield J. E., Moolchan E. T. Correlates of expired air carbon monoxide: effect of ethnicity and relationship with saliva cotinine and nicotine. Nicotine Tob Res 2001 3 : 325 31.
39. Son B. K., Markovitz J. H., Winders S., Smith D. Smoking, nicotine dependence, and depressive symptoms in the CARDIA study. Am J Epidemiol 1997 145 : 110 16.
40. Li M. D., Cheng R., Ma J. Z., Swan G. E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003 98 : 23 31.
41. Lerman C., Caporaso N. E., Audrain J., Main D., Bowman E. D., Lockshin B. et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999 18 : 14 20.
42. Sabol S. Z., Nelson M. L., Fisher C., Gunzerath L., Brody C. L., Hu S. et al. A genetic association for smoking behavior. Health Psychol 1999 18 : 7 13.
43. Spitz M. R., Shi H., Yang F., Hudmon K. S., Jiang H., Chamberlain R. M. et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998 90 : 358 63.
44. Shields P. G., Lerman C., Audrain J., Bowman E. D., Main D., Boyd N. R. et al. Dopamine D4 receptors and the risk of cigarette smoking in African Americans and Caucasians. Cancer Epidemiol Biomarkers 1998 7 : 453 8.
45. Bierut L. J., Rice J. P., Edenberg H. J., Goate A., Foroud T., Cloninger C. R. et al. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 2000 90 : 299 302.
46. Jorm A. F., Henderson A. S., Jacomb P. A., Christensen H., Korten A. E., Rodgers B. et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am J Med Genet 2000 96 : 331 4.
47. McKinney E. F., Walton R. T., Yudkin P., Fuller A., Haldar N. A., Mant D. et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000 10 : 483 91.
48. David S. P., Johnstone E., Griffiths S. E., Murphy M., Yudkin P., Mant D. et al. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics 2002 12 : 265 8.
49. Benowitz N. L., Jacob P. III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994 56 : 483 93.
50. Messina E. S., Tyndale R. F., Sellers E. M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997 282 : 1608 14.
51. Dempsey D., Tutka P., Jacob P. Allen F., Schoedel K., Tyndale R. F. et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004 76 : 64 72.
52. Benowitz N. L., Jacob P. III. Trans-3′-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol 2001 51 : 53 9.
53. Ariyoshi N., Sawamura Y., Kamataki T. A novel single nucleotide polymorphism altering stability and activity of CYP2a6. Biochem Biophys Res Commun 2001 281 : 810 14.
54. Xu C., Rao Y. S., Xu B., Hoffmann E., Jones J., Sellers E. M. et al. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem Biophys Res Commun 2002 290 : 318 24.
55. Rao Y., Hoffmann E., Zia M., Bodin L., Zeman M., Sellers E. M. et al. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 2000 58 : 747 55.
56. Ando M., Hamajima N., Ariyoshi N., Kamataki T., Matsuo K., Ohno Y. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J Epidemiol 2003 13 : 176 81.
57. London S. J., Idle J. R., Daly A. K., Coetzee G. A. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 1999 353 : 898.
58. Loriot M. A., Rebuissou S., Oscarson M., Cenee S., Miyamoto M., Ariyoshi N. et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics 2001 11 : 39 44.
59. Carter B., Long T., Cinciripini P. A meta-analytic review of the CYP2A6 genotype and smoking behavior. Nicotine Tob Res 2004 6 : 221 7.
60. Hansen E. S., International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis - a review of the epidemiological evidence. Mutat Res 1990 239 : 163 79.
61. Shimasaki Y., Yasue H., Yoshimura M., Nakayama K., Ogawa H., Harada E. et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998 31 : 1506 10.
62. Persson I., Johansson I., Ingel-Sundberg M. In vitro kinetics of two human CYP1A2 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 1997 231 : 227 30.
63. Smart J., Daly A. K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 2000 10 : 11 24.
64. Parkin D. M. International variation. Oncogene 2004 23 : 6329 40.
65. Vineis P., Malats N., Lang M., D'Errico A., Caporaso N., Cuzick J. et al. Metabolic Polymorphisms and Susceptibility to Cancer. Oxford : Oxford University 1999.
66. Raunio H., Husgafvel-Pursianinen K., Anttila S., Hietanen E., Hirvonen A., Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review. Gene 1995 159 : 113 21.
67. Stern M., Umbach D., van Gils C., Lunn R., Taylor J. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers 2001 10 : 125 31.
68. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphisms of CYP genes, alone or in combination, as risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers 2000 9 : 3 28.
69. Cardon L., Bell J. Association study designs for complex diseases. Nat Rev Genet 2001 2 : 91 9.
70. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment. Cancer Epidemiol Biomarkers 2001 10 : 1233 7.
71. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 2000 464 : 65 76.
72. Pavanello S., Clonfer E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 2000 463 : 285 308.
73. Sram R. J., Binkova B. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999. Environ Health Perspect 2000 108 : 57 70.
74. Barbujani G., Magagni A., Minch E., Cavalli-Sforza L. L. An apportionment of human DNA diversity. Proc Natl Acad Sci USA 1997 94 : 4516 19.
75. Templeton A. R. Human races: a genetic and evolutionary perspective. Am Anthropol 1999 100 : 632 50.
76. Cooper R., Rotimi C., Kaufman J., Owoaje E. E., Fraser H., Forrester T. et al. Prevalance of NIDDM among populations of the African diaspora. Diabetes Care 1997 20 : 343 8.
77. Banini A., Allen J., Allen H., Boyd L., Lartey A. Fatty acids, diet, and body indices of type II diabetic American whites and blacks and Ghanaians. Nutrition 2003 19 : 722 6.
78. Gibson P., Henry R., Shah S., Powell H., Wang H. Migration to a western country increases asthma symptoms but not eosinophilic airway inflammation. Pediatr Pulmonol 2003 36 : 209 15.
79. Hopkins P. N. Effects of dietary cholesterol on serum cholesterol: a meta-. analysis and review. Am J Clin Nutr 1992 55 : 1060 70.
80. Truswell A. S. Food carbohydrates and plasma lipids - an update. Am J Clin Nutr 1994 59 : 710S 718S.
81. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet 1993 342 : 1007 11.
82. Rimm E. B., Willett W. C., Hu F. B., Sampson L., Colditz G. A., Manson J. E. et al. Folate and Vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 1998 279 : 359 64.
83. Ascherio A., Rimm E. B., Giovannucci E. L., Spiegelman D., Stampfer M., Willett W. C. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. Br Med J 1996 313 : 84 90.
84. de Roos N. M., Schouten E. G., Katan M. B. Trans fatty acids, HDL-cholesterol, and cardiovascular disease. Effects of dietary changes on vascular reactivity. Eur J Med Res 2003 8 : 355 7.
85. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R. et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995 24 : 308 15.
86. Kris-Etherton P., Daniels S. R., Eckel R. H., Engler M., Howard B. V., Krauss R. M. et al. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation 2001 103 : 1034 9.
87. Mori T. A., Beilin L. J. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2000 12 : 11 17.
88. Rimm E. B., Stampfer M. J. Antioxidants for vascular disease. Med Clin North Am 2000 84 : 239 49.
89. Rimm E. B., Ascherio A., Giovannucci E., Spiegelman D., Stampfer M. J., Willett W. C. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. J Am Med Assoc 1996 275 : 447 51.
90. Brouwer I. A., van Dusseldorp M., Thomas C. M., Duran M., Hautvast J. G., Eskes T. K. et al. Low dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trail. Am J Clin Nutr 1999 69 : 99 104.
91. Newman P. E. Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Med Hypotheses 1999 53 : 421 4.
92. Zaina S., Lindholm M. W., Lund G. Nutrition an aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocyteinemia? J Nutr 2005 135 : 5 8.
93. Elliott P., Stamler J., Nicholas R., Dyer A. R., Stamler R., Kesteloot H. et al. Intersalt revisited: further analysesfor 24 h sodium excretion and blood pressure withinand across populations. Intersalt Cooperative Research Group. Br Med J 1996 312 : 1249 53.
94. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, and Prevention of Cancer: A Global Perspective. Washington, DC : American Institute for Cancer Research 1997.
95. Hunter D. J., Spiegelman D., Adami H. O., Beeson L., van den Brandt P. A., Folsom A. R. et al. Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med 1996 334 : 356 61.
96. Smith-Warner S. A., Spiegelman D., Yaun S. S., Adami H. O., Beeson W. L., van den Brandt P. A. et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. J Am Med Assoc 2001 285 : 769 76.
97. Smith-Warner S. A., Ritz J., Hunter D. J., Albanes D., Beeson W. L., van den Brandt P. A. et al. Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers 2002 11 : 987 92.
98. Curry S., Byers T., Hewitt M., editors. Fulfilling the Potential of Cancer Prevention and Early Detection. Washington, DC : National Academies Press 2003.
99. Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 1985 150 : 33 41.
100. Lampe J. W., Chen C., Li S., Prunty J., Grate M. T., Meehan D. E. et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers 2000 9 : 787 93.
101. Aldecruetz H. Phyto-oestrogens and cancer. Lancet Oncol 2002 3 : 364 73.
102. Yang C. S., Landau J. M., Huang M. T., Newmark H. L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001 21 : 381 406.
103. Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A. et al. Effects of a combination of beat carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996 334 : 1150 5.
104. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994 330 : 1029 35.
105. Milner J. A. Incorporating basic nutrition science into health interventions for cancer prevention. J Nutr 2003 133 : 3820S 3826S.
106. Larsson S. C., Giovannucci E., Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers 2005 14 : 740 3.
107. Davis C. D., Uthus E. O. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. Nutrition 2003 133 : 2907 14.
108. Hoppe C., Molgaard C., Thomsen B. L., Juul A., Michaelsen K. F. Protein intake at 9 mo of age is associated with body size but not with body fat in 10-y-old Danish children. Am J Clin Nutr 2004 79 : 494 501.
109. Godfrey K. M., Barker D. J. Fetal programming and adult health. Public Health Nutr 2001 4 : 611 24.
110. Simon J. A., Schreiber G. B., Crawford P. B., Frederick M. M., Saby Z. I. Income and racial patterns of dietary vitamin C intake among black and white girls. Public Health Rep 1993 108 : 760 4.
111. Champagne C. M., Bogle M. L., McGee B. B., Yadrick K., Allen H. R., Kramer T. R. et al. Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J Am Diet Assoc 2004 104 : 199 207.
112. Ranganathan R., Nicklas T. A., Yang S. J., Berenson G. S. The nutritional impact of dairy product consumption on dietary intakes in adults (1995-1996): the Bogalusa Heart Study. J Am Diet Assoc 2005 105 : 1391 400.
113. Shankar P., Dilworth J. E. L., Cone D. Dietary intake and health behavior among black and white college females. Fam Consum Sci Res J 2004 33 : 159 71.
114. Diaz V. A., Mainous A. G. 3rd, Koopman R. J., Carek P. J., Geesey M. E. Race and diet in the overweight: association with cardiovascular risk in a nationally representative sample. Nutrition 2005 21 : 718 25.
115. Hargreaves M. K., Baquet C., Gamshadzah A. Diet, nutritional status, and cancer risk in American blacks. Nutr Cancer 1989 12 : 1 28.
116. Kumanyika S., Shankar S., Mitchell P., Ganganna P., Smith S. A., Thompson L. et al. Recommended Strategies for Dietary Modification. Report of the Technical Advisory Panel on Dietary Modification. Washington, DC : U.S. Department of Health and Human Services, Bureau of Cancer Control 1990.
117. Patterson B. H., Block G., Rosenberger W., Pee D., Kahle L. Fruit and vegetables in the American diet: data from the NHANES II survey. Am J Public Health 1990 80 : 1443 9.
118. Stables G. J., Subar A. F., Patterson B. H., Dodd K., Heimendinger J., van Duyn M. A. S. et al. Changes in vegetables and fruit consumption and awareness among US adults: results of the 1991 and 1997 5-a-day for better health program surveys. J Am Diet Assoc 2002 102 : 809 17.
119. Rashid M. N., Fuentes F., Touchon R. C., Wehner P. S. Obesity and the risk for cardiovascular disease. Prev Cardiol 2003 6 : 42 7.
120. Calle E. E., Rodriquez C., Walker-Thurmond K., Thun M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003 348 : 1625 38.
121. Doria-Rose V. P., Newcomb P. A., Morimoto L. M., Hampton J. M., Trentham-Dietz A. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Cause Control 2006 17 : 63 70.
122. Lowenfels A. B., Maisonneuve P. Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin N 2002 16 : 1 16.
123. Li S. D., Mobarhan S. Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Nutr Rev 2000 58 : 54 6.
124. Qian Y., Fan J. G. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int 2005 4 : 173 7.
125. Bianchini F., Kaaks R., Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002 3 : 565 74.
126. Lindblad M., Rodriguez L. A., Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Cause Control 2005 16 : 285 94.
127. Yun J. E., Jo I., Park J., Kim M. T., Gun Ryu H., Odongua N. et al. Cigarette smoking, elevated flasting serum glucose, and risk of pancreatic cancer in Korean men. Int J Cancer 2006 119 : 208 12.
128. Larsson S. C., Permert J., Hakansson N., Naslund I., Bergkvist L., Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005 93 : 1310 15.
129. Hursting S. D., Lavigne J. A., Berrigan D., Perkins S. N., Barrett J. C. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicicability to humans. Annu Rev Med 2003 54 : 131 52.
130. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000 36 : 1224 8.
131. American Obesity Association. Obesity in America Fact Sheet, 2005. Available at: http://www.obesity.org/subs/fastfacts/obesityUS.shtml (accessed 22 November 2005).
132. National Center for Health statistics. Age-Adjusted Prevalence of Obesity Among Adults Aged 20 and Over, by Sex and Race/Ethnicity: United States, 2001. Available at: http://www.cdc.gov/nchs/about/major/nhis/released200207/ figure06_3.htm (accessed 15 November 2005).
133. Okosum I. S., Boltri J. M., Anochie L. K., Chandra K. M. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risks of abdominal obesity. J Hum Hypertens 2004 18 : 849 55.
134. Li T. Y., Rana J. S., Manson J. E., Willett W. C., Stampfer M. J., Colditz G. A. et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006 113 : 499 506.
135. Stampfer M. Weight loss and mortality: what does the Evidence show? Plos Med 2005 2 : e181. Published online 2005 June 28: 10.1371/journal.pmed.0020181.
136. Rehm J., Bondy S. Alcohol and all cause mortality: an overview. Novartis Found Symp 1998 216 : 223 32.
137. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 1993 15 : 328 51.
138. Gaziano J. M., Buring J. E., Brestlow J. L., Goldhaber S. Z., Rosner B., VanDenburgh M. et al. Moderate alcohol intake increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993 329 : 1829 34.
139. Seitz H. K., Poschl G., Simanowski U. A. Alcohol and cancer. Recent Dev Alcohol 1998 14 : 67 95.
140. La Vecchia C., Tavani A., Franceschi S., Levi F., Corrao G., Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997 33 : 302 12.
141. Mashberg A., Boffetta P., Winkelmann R., Garfinkel L. Tobacco smoking, alcohol drinking and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993 72 : 1369 75.
142. Salaspuro M. Alcohol consumption and cancer of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003 17 : 679 94.
143. Smith C. J., Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol 2000 38 : 637 46.
144. Albano E., Clot P. Free radicals and ethanol toxicity. In : Preedy V. R., Watson R. R., editors. Alcohol and the Gastrointestinal Tract. Boca Raton, FL : CRC Press 1996, p. 57 68.
145. Purulete M., Al-Ghnaniem R., Leather A. J., Appleby P., Gout S., Terry C. et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003 124 : 1240 8.
146. National Center for Health Statistics. Age-Sex-Adjusted Percent of Adults Aged 18 Years and Over with Excessive Alcohol Consumption, by Race/Ethnicity: United States, 2001. Available at: http://www.cdc.gov/nchs/about/major/nhis/ released200207/figure09_3.htm (accessed 15 November 2005).
147. Gritz E. R., Vidrine D. J., Lazev A. B., Amick B. C. 3rd, Arduino R.C. Smoking behavior in a low income multiethnic HIV/AIDS population. Nicotine Tob Res 2004 6 : 71 7.
148. Harris T. Recent developments in understanding the psychosocial aspects of depression. Br Med Bull 2001 57 : 17 32.
149. Kessler R. C. The effects of stressful life events on depression. Annu Rev Psychol 1997 48 : 191 214.
150. Bairey M. C. N., Dwyer J., Nordstrom C. K., Walton K. G., Salerno J. W., Schneider R. H. Psychosocial stress and cardiovascular disease: pathophysiological links. Behav Med 2002 27 : 141 7.
151. Black P. H., Garbutt L. D. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002 52 : 1 23.
152. Yeung A. C., Vekshtein V. I., Krantz D. S., Vita J. A., Ryan T. J. Ganz P. et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991 325 : 1551 6.
153. McEwen B. S. The neurobiology of stress: rrom serendipity to clinical relevance. Brain Res Rev 2000 886 : 172 89.
154. Song C., Kenis G., Van Gastel A., Bosmans E., Lin A., de Jong R. et al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations on natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatr Res 1999 85 : 293 303.
155. Uchakin P. N., Tobin B., Cubbage M., Marshall G. Sams C. Immune responsiveness following academic stress in first-year medical students. J Interferon Cytokine Res 2001 21 : 687 94.
156. Kaufman J., Birmaher B., Perel J., Dahl R. E., Moreci P., Nelson B. et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol Psychiatry 1997 42 : 669 79.
157. Heim C., Newport D. J., Graham Y. P., Bonsall R., Miller A. H., Nemeroff C. B. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001 158 : 575 81.
158. Vythilingam M., Heim C., Newport J., Miller A. H., Anderson E., Bronen R. et al. Childhood trauma associated with smaller hippocampal Volume in women with major depression. Am J Psychiatry 2002 159 : 2072 80.
159. Drell T. L., Joseph J., Lang K., Niggemann B., Zaenker K. S., Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human carcinoma cells. Breast Cancer Res Treat 2003 80 : 63 70.
160. Eskandari F., Sternberg E. M. Neural-immune interactions in health and disease. Ann NY Acad Sci 2002 966 : 20 7.
161. Beckler A., Moskaluk C. A., Zaika A., Hampton G. M., Powell S. M., Frierson H. F. Jr. et al. Overexpression of the 32-kilodalton dopamine and cyclic-3′,5′-monophosphate-regulated phosphoprotein in common adenocarcinomas. Cancer 2003 98 : 1547 51.
162. Yao G. Y., Zhou J. L., Lai M. D., Chen X. Q., Chen P. H. Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol 2003 9 : 858 61.
163. Anglin I. E., Glassman D. T., Kyprianou N. Induction of prostate apoptosis by alpha 1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis 2002 5 : 88 95.
164. Banerjee D. K. Angiogenesis: characterization of a cellular model. PR Health Sci J 1998 17 : 327 33.
165. Masur K., Niggemann B., Zanker K. S., Entschladen F. Norepinehrine- induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 2001 61 : 2866 9.
166. Garcia-Solis P., Aceves C. 5′Deiodinase in two breast cancer cell lines: effect of triiodothronine, isoproterenol and retinoids. Mol Cell Endocrinol 2003 201 : 25 31.
167. Pennington J. D., Wang T. J., Nguyen P., Sun L., Bisht K., Smart D. et al. Redox-sensitive signaling factors as novel molecular targets for cancer therapy. Drug Resist Updat 2005 8 : 322 30.
168. Poulsen H. E. Oxidative DNA modifications. Exp Toxicol Pathol 2005 57 : 161 9.
169. Engel R. H., Evens A. M. Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci 2006 11 : 300 12.
170. Herberman R. B., Ortaldo J. R. Natural killer cells: their roles in defenses against disease. Science 1981 214 : 24 30.
171. Roder J., Pross H. The biology of the human natural killer cell. J Clin Immunol 1982 2 : 249 63.
172. Levy S. M., Herberman R. B., Lippman M., D'Angelo T., Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 1991 17 : 67 75.
173. Whiteside T. L., Herberman R. B. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 1995 7 : 704 10.
174. Epel E. S., Blackburn E. H., Lin J., Dhabbar F. S., Adler N. E., Morrow J. D. et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004 101 : 17312 15.
175. Wills T. A., Shiffman S. Coping and substance use: a conceptual framework. In : Shiffman S. W. Wills T. A., editors. Coping and Substance Use. Orlando, FL : Academic Press 1985, p. 3 24.
176. Gottlieb N. H., Green L. W. Ethnicity and Lifestyle Health Risk: some possible mechanisms. Am J Health Promot 1987 2 : 37 45.
177. Romano P. S., Bloom J., Syme L. Smoking, social support, and hassles in an urban African-American community. Am J Public Health 1991 81 : 1415 22.
178. Feigelman W., Gorman B. Toward explaining the higher incidence of cigarette smoking among Black Americans. J Psychoactive Drugs 1989 21 : 299 305.
179. Bennett G. G., Wolin K. Y., Robinson E. L., Fowler S., Edwards C. L. Perceived racial/ethnic harassment and tobacco use among African-American young adults. Am J Public Health 2005 95 : 238 40.
180. Guthrie B. J., Young A. M., Williams D. R., Boyd N. R., Kintner E. K. African-American girls' smoking habits and day-to-day experiences with racial discrimination. Nurs Res 2002 51 : 183 90.
181. Landrine H., Klonoff E. A. The schedule of racist events: a measure of racial discrimination and a study of its negative physical and mental consequences. J Black Psychol 1996 22 : 144 68.
182. Landrine H., Klonoff E. A. Racial discrimination and cigarette smoking among blacks: findings from two studies. Ethn Dis 2000 10 : 195 202.
183. Landrine H., Klonoff E. A. Racial segregation and cigarette smoking among Blacks: findings at the individual level. J Health Psychol 2000 5 : 211 19.
184. Fernander A. F., Duran R. E. F., Saab P. G., Schneiderman N. John Henry active coping, education, and blood pressure among urban blacks. J Natl Med Assoc 2004 96 : 246 55.
185. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom K. O. The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991 86 : 1119 27.
186. Fagan P., King G., Lawrence D., Petrucci S. A., Robinson R. G., Bnaks D. et al. Eliminating tobacco-related health disparities: directions for future research. Am J Public Health 2004 94 : 211 17.
187. Landrine H., Richardson J. L., Klonoff E., Flay B. Cultural diversity in the predictors of adolescent cigarette smoking: the relative influence of peers. J Behav Med 1994 17 : 331 46.
188. Yu E. S., Chen E. H., Kim K. K. Smoking among Chinese Americans: behavior, knowledge, and beliefs. Am J Public Health 2002 92 : 1007 12.
189. Kaplan C. P., Napoles-Springer A., Stewart S. L., Perez-Stable E. J. Smoking acquisition among adolescents and young Latinas: the role of socioenvironmental and personal factors. Addict Behav 2001 26 : 531 50.
190. Landrine H., Klonoff E. A. The African American acculturation scale: development, reliability, and validity. J Black Psychol 1994 20 : 104 27.
191. Markides K. S., Coreil J., Ray L. A. Smoking among Mexican Americans: a three-generation study. Am J Public Health 1987 77 : 708 11.
192. Tomatis L., Huff J., Hertz-Picciotto I., Sandler D. P., Bucher J., Boffetta P. et al. Avoided and avoidable risks of cancer. Carcinogenesis 1997 18 : 97 105.
193. McCauley L. A. Chemical mixtures in the workplace. AAOHN J 1998 46 : 29 40.
194. Chow C. K. Vitamin E and oxidative stress. Free Radic Biol Med 1991 11 : 215 32.
195. Rossman T. G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 2003 533 : 37 65.
196. Moore L. E., Huang W.-Y., Chung J., Hayes R. B. Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer. Ann NY Acad Sci 2003 983 : 181 96.
197. Toyooka S., Maruyama R., Toyooka K. O., McLerran D., Feng Z., Fukuyama Y. et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003 103 : 153 60.
198. Shen L., Ahuja Y., Shen Habib N. A., Toyota M., Rashid A., Issa J. P. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002 94 : 755 61.
199. Woodson K., Hayes R., Wideroff L., Villaruz L., Tangrea J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US blacks and whites. Prostate 2003 55 : 199 205.
200. Shavers V. L., Shavers B. S. Racism and health inequity among Americans. J Natl Med Assoc 2006 98 : 386 93.
201. Brown P. Race, class, and environmental health - a review and systematization of the literature. Environ Res 1995 69 : 15 30.
202. Institute of Medicine. Toward Environmental Justice: Research, Education, And. Health Policy Needs. Washington, DC : National Academies Press 1999.
203. Cade J., Thompson R., Burley V., Warm D. Development, validation, and utilization of food-frequency questionnaires - a review. Public Health Nutr 2002 5 : 567 87.
204. Kristal A. R., Peters U., Potter J. D. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers 2005 14 : 2826 8.
205. Volkel W., Alvarez-Sanchez R., Weick I., Mally A., Dekant W., Pahler A. Glutathione conjugates of 4-hydroxy-2 (E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. Free Radic Biol Med 2005 38 : 1526 36.
206. Skrzydlewska E., Stankiewicz A., Sulkowska M., Sulkowski S., Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health 2001 64 : 213 22.
207. Wood L. G., Fitzgerald D. A., Gibson P. G., Cooper D. M., Garg M. L. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000 35 : 967 74.
208. Watson W. P., Mutti A. Role of biomarkers in monitoring exposures to chemicals: present position, future prospects. Biomarkers 2004 9 : 211 42.
209. Brena R. M., Huang T. H.-M., Plass C. Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med 2006 84 : 1 13.
210. Li S., Hursting S. D., Davis B. J., McLachlan J. A., Barrett J. C. Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann NY Acad Sci 2003 983 : 161 9.
211. Merrick B. A., Bruno M. E. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr Opin Mol Ther 2004 6 : 600 7.
212. Kaminska I. A., Oldak A., Turski W. A. Geographical information system (GIS) as a tool for monitoring and analyzing pesticide pollution and its impact on public health. Ann Agric Environ Med 2004 11 : 181 4.